The drug booster to the brain

,
Sometimes drugs need a bigger push to be more effective and reach their final destination:Expansion

Sometimes drugs need a bigger push to be more effective and reach their final destination: the brain. The three families of peptides (proteins) developed and patented by Gate2Brain fulfill this mission by acting as a shuttle or tractor for drugs to act on this organ and treat localized pathologies.

This development led by Meritxell Teixidó, CEO of the company, after several years of work, has been possible thanks to a team of researchers and professionals from the University of Barcelona, ​​IRB Barcelona and Hospital Sant Joan de Déu. The first application of this technology will be for the treatment of pediatric cancer, when it is located in the brain.

“We are currently in the preclinical phase and the first clinical trial with pediatric patients is scheduled for 2026, at the Sant Joan de Déu Hospital, a reference center for childhood diseases”, explains Teixidó. The company has recently drawn the attention from the EIC Accelerator program of the European Union, which has injected 2.5 million euros into it.

Source: Expansión Start Up

/by
You might also like
BioSpain2021Gate2Brain attending BioSpain 2021
Gate2Brain will be attending in Basel, Switzerland, the Investment Readiness Series, a @Biocat initiative co-organized by the Delegation of the Government of Catalonia in Switzerland, The aim of the meeting is to put the best projects - from companies and/or research organizations - in contact with investors, business angels, venture capitalists and leading Swiss companies.Gate2Brain will be attending The Investment Readiness Series
Una tecnología para ayudar a tratar el cáncer infantilgate2brainA technology to help treat pediatric cancer
Next Wednesday, February 16, @Gate2Brain will be in #Transfiere, European Forum for Science, Technology and Innovation to be held in Malaga. Our CEO, @Meritxell Teixidó, will participate as a speaker together with 16 other companies, at the #Boosting Zone for being one of the companies that have been awarded the #NEOTEC2021 program of the @CDTI, Centro para el Desarrollo Tecnológico Industrial. Boosting Zone is a space for promoting innovation and technology transfer from scientific-based companies.TransfiereGate2Brain in Transfiere – European Forum for Science, Technology & Innovation
Gate2Brain among the 5 Catalan startups that have obtained funding from EIC AcceleratorcanvaGate2Brain among the 5 Catalan startups that have obtained funding from EIC Accelerator
medicines beyond barriersG2BMedicines beyond barriers
Nadia Calviño, First Vice President of the Government and Minister of Economic Affairs visits Gate2BrainSJDNadia Calviño, First Vice President of the Government visits Gate2Brain
talento científicotalento cientificoFounding a company in times of pandemic
Gate2Brain

Gate2Brain is a biotech company focused on the development of therapeutics that efficiently cross biological barriers such as the blood-brain barrier. We use a radically innovative peptide-based patented technology.

Where to find us

Barcelona Scientific Park
Baldiri Reixac, 4-8, Torre I
08028 Barcelona, Spain
info@gate2brain.com

Social

G2B at Transfiere 2023Gate2Brain at TransfiereG2BG2B at 4YFN 2023G2BGate2Brain at 4YFN-MWC23